Purchase Order 75N98F18P00029

<p>The National Institutes of Health Clinical Center awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $10,807.60 on August 22, 2018, for RNA probes and advanced cell diagnostics products. Performance is located in Newark, California. The order carries a firm fixed price, with an ultimate completion date of August 30, 2018. No set-aside category applies.</p>

The National Institute of Neurological Disorders and Stroke awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $6,244.40 on July 9, 2018, for a firm fixed price commercial acquisition with no set-aside category. The order was completed by July 8, 2019. Performance took place in Newark, California. The order procured RNA detection technologies and related diagnostic products from Advanced Cell Diagnostics' RNAscope platform, which the vendor supplies to federal research...

<p>The National Institute of Child Health and Human Development awarded a purchase order to Advanced Cell Diagnostics, Inc. for $10,000.00 on September 22, 2017, with completion by December 22, 2017. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for RNA detection technologies and related diagnostic products, consistent with Advanced Cell Diagnostics' RNAscope platform and specialized molecular pathology solutions supporting NIH research programs.</p>

Advanced Cell Diagnostics, Inc. has been awarded an $11,183.20 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNAscope assay biological products including kits, reagents and probes. As a leader in molecular pathology, Advanced Cell Diagnostics will supply its proprietary RNAScope platform and accompanying products to support the federal research programs of the Department of Health and Human Services agency....

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $16,580 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for RNAScope under contract number 1187802. Advanced Cell Diagnostics, Inc. will deliver its cell diagnostics technology from its Newark, California location under the eight-month contract ending in March 2024. As part of the National Institutes of Health's medical research efforts, this contract provides RNAScope, a...

<p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $11,593.00 on May 28, 2021, for RNAscope technology and related reagents. Work is performed in Newark, California. The purchase order, issued under firm fixed-price terms with no set-aside, provides RNA detection and visualization capabilities for identifying TGF-beta isoforms in normal tissues and tumors using minimal sample material. The order closes on June 27, 2021.</p>

<p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. for laboratory testing with a ceiling value of $19,772.00 and an award date of August 13, 2020. The order carries no set-aside designation and firm fixed pricing. Work is performed in Newark, California. The purchase order has an ultimate completion date of September 30, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. for laboratory and testing services valued at $12,345.00, effective August 6, 2020. Performance will take place in Newark, California, with ultimate completion by September 4, 2020. The order carries firm fixed pricing and no set-aside designation.</p>

This is a $13,793.20 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The contract is for the delivery of 12 custom RNAscope probes and an RNAscope fluorescent reagent kit, which will support various biomedical research efforts across NIAID and...

This firm-fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The $20,000.00 contract supports ACD's provision of its proprietary RNAscope reagents, kits, probes, and related services to aid various biomedical research efforts across NIH and its institutes, including the National Cancer Institute, National Institute of...